QuidelOrtho Corp

Nasdaq:QDEL

In Vitro & In Vivo Diagnostic Substances·SAN DIEGO, CA

QuidelOrtho Corporation is an American manufacturer of diagnostic healthcare products that are sold worldwide.

CEO

Blaser Brian J.

CFO

Busky Joseph M.

Financials

16 shown

Type	Period	Ended	Filed
10-K	FY 2025	12/28/25	2/19/26	→
10-Q	Q3 2025	9/28/25	11/6/25	→
10-Q	Q2 2025	6/29/25	8/6/25	→
10-Q	Q1 2025	3/30/25	5/8/25	→
10-K	FY 2024	12/29/24	2/27/25	→
10-Q	Q3 2024	9/29/24	11/8/24	→
↓

Earnings Releases (8-K)

20 shown

Filed	Period
2/11/26	Q4 FY2027	→
11/5/25	Q3 FY2026	→
8/5/25	Q2 FY2026	→
5/7/25	Q1 FY2026	→
2/12/25	Q4 FY2026	→
1/13/25	Q4 FY2025	→
↓

News (8-K)

26 shown

Filed	Type	Description
2/13/26	Exec Change	Departure or Appointment of Directors or Certain Officers	→
2/5/26	Exec Change	Departure or Appointment of Directors or Certain Officers	→
11/10/25	Reg FD	Regulation FD Disclosure	→
8/21/25	Agreement	Entry into a Material Definitive Agreement	→
5/27/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
3/4/25	Other	Changes in Registrant's Certifying Accountant	→
↓

Prospectuses & Registrations

13 shown

Filed	Form	Description
6/30/25	S-8	S-8	→
4/8/25	ARS	ARS	→
11/20/24	424B3	424B3	→
11/19/24	FWP	FWP	→
11/19/24	S-3ASR	S-3ASR	→
4/2/24	ARS	ARS	→
↓

Filing History(432 filings)

TypeDateAccessionPeriodSize

4/A

Feb 19, 2026

0001385091-26-000010FORM 4/A

Feb 13, 2026

5.8 KB

10-K

Feb 19, 2026

0001906324-26-00000810-K

Dec 28, 2025

14.4 MB

8-K

Feb 13, 2026

0001193125-26-0514618-K

Feb 9, 2026

127.6 KB

Feb 13, 2026

0001377832-26-000003FORM 4

Feb 13, 2026

7.2 KB

SCHEDULE 13G/A

Feb 13, 2026

0001104659-26-015233

—

10.2 KB

Feb 13, 2026

0001385091-26-000008FORM 4

Feb 13, 2026

5.2 KB

Feb 13, 2026

0001492289-26-000006FORM 4

Feb 13, 2026

5.6 KB

SCHEDULE 13G

Feb 12, 2026

0000914208-26-000054

—

12.8 KB

8-K

Feb 11, 2026

0001906324-26-0000038-K

Feb 11, 2026

707.0 KB

Feb 10, 2026

0001833942-26-000006FORM 4

Feb 8, 2026

8.6 KB

Feb 10, 2026

0001385091-26-000006FORM 4

Feb 8, 2026

9.2 KB

8-K

Feb 5, 2026

0001193125-26-0394408-K

Jan 30, 2026

127.9 KB

SCHEDULE 13G/A

Feb 5, 2026

0000315066-26-000528

—

11.2 KB

Feb 3, 2026

0002036238-26-000004FORM 4

Jan 30, 2026

7.5 KB

Feb 3, 2026

0002045799-26-000004FORM 4

Jan 30, 2026

27.1 KB

Feb 3, 2026

0002040321-26-000004FORM 4

Jan 30, 2026

7.5 KB

Feb 3, 2026

0001833942-26-000004FORM 4

Jan 30, 2026

17.6 KB

Feb 3, 2026

0001385091-26-000004FORM 4

Jan 30, 2026

5.5 KB

Feb 3, 2026

0001492289-26-000004FORM 4

Jan 30, 2026

5.5 KB

Feb 2, 2026

0002040321-26-000002FORM 4

Jan 29, 2026

8.5 KB

Feb 2, 2026

0002045799-26-000002FORM 4

Jan 29, 2026

8.5 KB

Feb 2, 2026

0001833942-26-000002FORM 4

Jan 29, 2026

8.9 KB

Feb 2, 2026

0002036238-26-000002FORM 4

Jan 29, 2026

8.5 KB

Feb 2, 2026

0001385091-26-000002FORM 4

Jan 29, 2026

9.3 KB

Feb 2, 2026

0001492289-26-000002FORM 4

Jan 29, 2026

9.2 KB

25 filings shown

Filed	Form	Description
4/8/25	DEFA14A	DEFA14A	→
4/8/25	DEF 14A	DEF 14A	→
4/2/24	DEFA14A	DEFA14A	→
4/2/24	DEF 14A	DEF 14A	→
4/5/23	DEFA14A	DEFA14A	→
4/5/23	DEF 14A	DEF 14A	→

QuidelOrtho Corp

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(432 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
2/19/26	4/A	FORM 4/A	→
2/13/26	4	4	→
2/13/26	4	4	→
2/13/26	4	4	→
2/10/26	4	4	→
2/10/26	4	4	→
↓